{Reference Type}: Letter
{Title}: Comment on: Carboplatin and irinotecan (CI) vs. Carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial.
{Author}: Furune S;Ando Y;
{Journal}: Lung Cancer
{Volume}: 186
{Issue}: 0
{Year}: 2023 12 28
{Factor}: 6.081
{DOI}: 10.1016/j.lungcan.2023.107416